Corient Private Wealth LP Invests $33.59 Million in Mettler-Toledo International, Inc. $MTD

Corient Private Wealth LP purchased a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 26,295 shares of the medical instruments supplier’s stock, valued at approximately $33,591,000. Corient Private Wealth LP owned about 0.13% of Mettler-Toledo International at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. XXEC Inc. bought a new position in shares of Mettler-Toledo International in the second quarter valued at approximately $77,044,000. BlackRock Inc. purchased a new stake in shares of Mettler-Toledo International during the second quarter valued at $2,404,713,000. Capital International Investors raised its holdings in Mettler-Toledo International by 12.7% during the 4th quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after buying an additional 109,508 shares during the period. T. Rowe Price Investment Management Inc. lifted its position in shares of Mettler-Toledo International by 0.5% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock valued at $964,174,000 after acquiring an additional 3,157 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Mettler-Toledo International by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock worth $830,879,000 after buying an additional 14,106 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In related news, insider Gerry Keller sold 240 shares of Mettler-Toledo International stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $1,427.14, for a total value of $342,513.60. Following the completion of the sale, the insider directly owned 259 shares in the company, valued at $369,629.26. This trade represents a 48.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Shawn Vadala sold 2,240 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the sale, the chief financial officer owned 5,579 shares of the company’s stock, valued at approximately $7,989,128. This represents a 28.65% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 3,312 shares of company stock worth $4,750,362 over the last 90 days. Insiders own 0.71% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on MTD. Wolfe Research began coverage on shares of Mettler-Toledo International in a report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Robert W. Baird lowered their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Wells Fargo & Company raised their price target on Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Citigroup dropped their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Finally, Wall Street Zen cut Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and an average target price of $1,461.27.

Mettler-Toledo International Stock Up 0.6%

Shares of MTD opened at $1,407.20 on Friday. The business’s 50 day simple moving average is $1,340.21 and its 200-day simple moving average is $1,274.17. The company has a debt-to-equity ratio of 159.45, a current ratio of 1.12 and a quick ratio of 0.78. Mettler-Toledo International, Inc. has a one year low of $1,023.05 and a one year high of $1,525.17. The company has a market capitalization of $28.20 billion, a P/E ratio of 31.67, a PEG ratio of 2.88 and a beta of 1.23.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Friday, July 31st. The medical instruments supplier reported $11.46 EPS for the quarter, topping analysts’ consensus estimates of $10.78 by $0.68. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the firm earned $10.09 EPS. The company’s revenue was up 4.5% on a year-over-year basis. As a group, sell-side analysts predict that Mettler-Toledo International, Inc. will post 47.35 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.